MarginsXMarginsX
Home › Markets › Health Care › APYX

Apyx Medical Corporation (APYX)

APYX trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.65
-5.69% on the day
Market cap
$111.6M
Micro cap
Revenue · 2025
$52.8M
+9.9% on 2024
Net income · 2025
-$11.2M
-21.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/719135/000143774926007471/0001437749-26-007471-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerAPYX on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000719135
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$52.8M
Net income-$11.2M
Operating income-$6.4M
Net margin-21.2%
Operating margin-12.2%
Revenue growth+9.9%
Cash$31.7M
Total assets$66.8M
P/E (computed)Net income was not positive
P/S (computed)2.1×

Warning signs

Cash runway
37.6 months
$25.8M cash at September 30, 2026
Share count, 1 year
+10.2%
2025-11-05 to 2026-11-04 · +21.6% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$25.8M cash; operating cash flow -$2.1M a quarter.Report 2026-09-30
Shares outstanding42,124,023 (2026-11-04); 38,241,905 a year earlier; 34,643,855 three years earlier.Cover page 2026-11-04
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2025-11-18
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorRSM US LLP, Tampa, Florida, United StatesPCAOB Form AP 2026-03-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$14.0M-$1.8M-$1.6M$25.8M$37.5M$59.6M10-Q 2026-11-05
Q2 2026
2026-06-30
$13.9M-$3.2M-$3.5M$27.6M$37.5M$58.4M10-Q 2026-08-06
Q1 2026
2026-03-31
$12.5M-$2.1M-$572K$31.1M$37.5M$55.9M10-Q 2026-05-07
Q4 2025
2025-12-31
$19.2M-$1.3M-$2.5M$31.7M$37.5M$52.8M10-K 2026-03-10
Q3 2025
2025-09-30
$12.9M-$2.0M-$3.5M$25.1M$37.5M$47.9M10-Q 2026-11-05
Q2 2025
2025-06-30
$11.4M-$3.8M-$1.2M$29.3M$37.5M$46.5M10-Q 2026-08-06
Q1 2025
2025-03-31
$9.4M-$4.2M-$702K$31.0M$37.5M$47.3M10-Q 2026-05-07
Q4 2024
2024-12-31
$14.2M-$4.6M-$2.9M$31.7M$37.5M$48.1M10-K 2026-03-10

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32025-12-01
Latest annual report
FORM 10-K
10-K2026-03-10
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-05
Latest current report
FORM 8-K
8-K2026-11-05
Latest proxy
FORM DEF 14A
DEF 14A2026-06-26

Source: SEC EDGAR submissions feed, 992 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-4.1%
1 month+8.1%
3 months-7.6%
Year to date-19.7%
1 year-31.0%
From 52-week high-42.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
SKYASkyAI Inc.$2.11-9.05%$107.3M
STIMNeuronetics Inc.$1.25-10.07%$120.6M
LUNGPulmonx Corporation$2.80-2.10%$121.9M
PYPDPolyPid Ltd.$6.15-1.76%$124.9M
SKINSkinHealth Systems Inc.$15.05-7.73%$98.5M
NYXHNyxoah SA$0.8937-0.64%$89.4M
LUCDLucid Diagnostics Inc.$0.3978-11.42%$82.3M
KRMDKORU Medical Systems Inc. Common Stock (DE)$3.69-0.27%$160.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier